Riskpilot← Back to searchSign inGet full accessAccresco Hälsa AB
ABActiveOrg 5591102511Vasagatan 65General medical practice activities · NACE 8621Est. 201710-19 employees
Revenue 2024
SEK 13,3M
-2% vs 2023
EBITDA margin
9.0%
-42% vs 2023
Equity ratio
21.9%
Financial strength
Net profit 2024
SEK 927K
-23% vs 2023
| Revenue | SEK 13,3M | -2% |
| EBITDA | SEK 1,2M | -42% |
| Net profit | SEK 927K | -23% |
| Total assets | SEK 5,5M | +6% |
| Equity | SEK 1,2M | -6% |
| Employees | — | — |
Legal name
Accresco Hälsa AB
Org number
5591102511
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
27 april 2017
Share capital
SEK 50 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolagets verksamhet är att tillhandahålla medicinska tjänster inom äldrevård, hemsjukvård och särskilda boenden, utföra företagshälsovård och skolhälsovård samt därmed förenlig verksamhet.
Address
Vasagatan 65
Email
info@accresco.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 14 582 | 14 721 | 16 564 | 13 587 | 13 257 |
| Staff expenses | — | — | — | — | −9 315 |
| EBITDA | 1 496 | 2 443 | 3 942 | 2 052 | 1 192 |
| Depreciation & amort. | −0 | −0 | −12 | −16 | −20 |
| EBIT | 1 496 | 2 443 | 3 930 | 2 036 | 1 172 |
| Net financials | −6 | −2 | 1 | 13 | 19 |
| Profit before tax | 1 490 | 1 831 | 2 931 | 1 520 | 1 187 |
| Tax | −324 | −382 | −612 | −323 | −260 |
| Net profit | 1 166 | 1 449 | 2 319 | 1 197 | 927 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 788 | 5 749 | 7 024 | 5 235 | 5 537 |
| Equity | 1 221 | 2 169 | 2 989 | 1 286 | 1 213 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 3 568 | 2 969 | 2 426 | 1 811 | 2 181 |
| Total debt | 3 568 | 2 969 | 2 426 | 1 811 | 2 181 |
EBITDA margin
9.0%
This company
15.8%
Market median
-43% vs market
20202024
Equity ratio
21.9%
This company
38.2%
Market median
-43% vs market
20202024
Return on equity
76.5%
This company
18.4%
Market median
+316% vs market
20202024
Net profit margin
7.0%
This company
8.1%
Market median
-14% vs market
20202024
Asset turnover
2.39×
This company
1.12×
Market median
+113% vs market
20202024
Debt / equity
3.56×
This company
0.62×
Market median
-474% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JR Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Accresco Hälsa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Rolf Hultelid | Audit | 0 companies |
| Pernilla Carina Ernst | Chairman | 0 companies |
| Ulf Roland Andersson | Deputy Board Member | 0 companies |
| Carolina Christina Westerdahl | Board of Directors | 0 companies |
| Åsa Johanna Andersson | Deputy Board Member | 0 companies |